Home > Insider Trading > Filing (0001213900-18-000046)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1518520	Icagen Inc.	NONE	()	4

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1024533	N Michael Taglich	C/O Icagen, Inc. 4222 Emperor Blvd., Suite 350, Research Triangle Park Durham, NC 27703		Yes	No	Yes	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	Acquisiton	2017-12-29	21,429	$0.37	62,727	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Warrant	Acquisiton	2017-12-29	5,358	$0.02	5,358	$3.50

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
5,358	2017-12-29	2019-12-31	No	4	A	Direct

Reported Non-Derivative Holdings

Sec. Name	Remaning Holdings	Nature of Ownership	Explanation
Common Stock, $0.001 Par Value	390,587	Indirect	See footnote

Footnotes

Mr. Taglich indirectly owns an aggregate of 390,587 shares of common stock of Icagen, Inc. as follows: (i) 285,714 shares held by the Michael N. Taglich Keogh-Account; (ii) an aggregate of 22,856 shares held by four separate custodial accounts for the benefit of Mr. Taglich's minor children; (iii) 16,933 shares held jointly by Mr. Taglich and his wife, Claudia Taglich; and (vii) 65,084 shares held by the Mike Taglich POA Tag/Kent Partnership F/B/O Garlinghouse/M Taglich B Taglich, with Mr. Taglich having power of attorney over the partnership.